Quest Diagnostics (DGX) Tops Q1 EPS by 25c, Raises FY EPS Guidance
Tweet
Share
E-mail
Get Alerts DGX Hot Sheet
Price: $244.88 -0.64%
EPS Growth %: +10.0%
Financial Fact:
Cost of services: 1.16B
Today's EPS Names:
ALZN, ASPU, OCCI, More
EPS Growth %: +10.0%
Financial Fact:
Cost of services: 1.16B
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Quest Diagnostics (NYSE: DGX) reported Q1 EPS of $3.22, $0.25 better than the analyst estimate of $2.97. Revenue for the quarter came in at $2.61 billion versus the consensus estimate of $2.63 billion.
GUIDANCE:
Quest Diagnostics sees FY2022 EPS of $9.00-$9.50, versus the consensus of $9.03.
For earnings history and earnings-related data on Quest Diagnostics (DGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CMS targets 15% Medicare lab fee cuts, putting DGX and LH revenue at risk
- Endava CFO placed on leave amid accounting probe
- RBC Capital Starts Tabcorp Holdings (TAH:AU) (TABCF) at Outperform
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
